cvb
cvb
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc.(VIR)

📊 Dividend Highlights

Last Dividend
$0.03
Approx. Annual Dividend
$0.10
Payment Frequency
Quarterly

Previous Payout History

13 payouts shown
Pay DateAmount Per ShareChange vs Previous
December 3, 2010$0.03-
September 17, 2010$0.03-
June 11, 2010$0.03-
March 19, 2010$0.03-
December 1, 2009$0.03-
September 15, 2009$0.03-
June 2, 2009$0.03-
March 9, 2009$0.03-
December 1, 2008$0.03-
September 16, 2008$0.03-
June 2, 2008$0.03-
March 7, 2008$0.03-
December 5, 2007$0.03

Overall Dividend Trend

Dividend per share has changed by0.00%over the past 3years(comparing first and last payout shown).

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc. is a cutting-edge immunology company specializing in the development of innovative solutions to combat serious infectious diseases. Founded in 2016 by Robert Nelsen and headquartered in San Francisco, California, the company's mission is to integrate immunologic insights with cutting-edge technologies to treat and prevent severe viral infections. Vir has made significant strides in addressing global health challenges, particularly with its development of antibody therapies against COVID-19, hepatitis B, and influenza. The firm's collaborative approach includes partnerships with renowned organizations and research institutions to accelerate the delivery of groundbreaking therapies. As of recent reports, the company has been actively expanding its robust pipeline, which reflects its commitment to enhancing global health outcomes and maintaining sustainable revenue growth.

📍1800 Owens Street, San Francisco, CA, 94158

📞415-906-4324

Dividend data last updated:Wed, 21 May 2025 03:06:28 GMT. Financial data is indicative and provided for informational purposes only.